ORLANDO, Fla.--(BUSINESS WIRE)--Mar. 12, 2012--
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, today introduced innovations that enable customers to improve
laboratory productivity – by delivering results faster and with greater
accuracy – while extending the boundaries of routine analysis. During
Pittcon, being held from March 11-15, in Orlando, the company will
showcase its scale and depth of capabilities across its three premier
brands: Thermo Scientific®, Fisher Scientific® and
Unity™ Lab Services.
Thermo Scientific booth 2665 highlights the company’s
industry-leading technology offering, including chromatography, mass
spectrometry, and trace elemental and molecular spectroscopy product
lines. Within Fisher Scientific booth 2871, customers can learn
about the RESULTS™
program, which makes it easier to purchase the products and supplies
needed for an entire application. The company’s newest brand, Unity
Lab Services, combines product and operations support to create a
single solution, and is featured in booths 2665 and 2871.
“In today’s increasingly competitive business climate, our customers in
a range of industries and environments are looking for ways to
measurably increase productivity while extending the use of advanced
analytical technologies to more routine applications,” said Marc N.
Casper, president and chief executive officer of Thermo Fisher
Scientific. “From the chromatography powerhouse we’ve created by
acquiring Dionex, to our new Unity Lab Services capability, we can
deliver a tightly integrated value proposition to customers based on the
most comprehensive offering in the industry.”
Greater Speed, Accuracy and Efficiency for a Range of Applications
For the first time at Pittcon, customers will see the result of
combining Thermo Scientific and Dionex™: a chromatography powerhouse
with an extensive offering of new instruments, consumables, columns
and software.
Among the chromatography innovations featured are two new high-pressure
capillary ion chromatography (IC) systems. The Thermo
Scientific Dionex ICS-4000 is the world’s first commercially
available integrated capillary high-pressure ion chromatography (HPIC™)
system, ideal for analyses in industries such as environmental, food and
beverage, pharmaceutical and biopharma. The Thermo
Scientific Dionex ICS-5000 is a modular system that offers
high-pressure capabilities to bring near-UHPLC performance to IC.
Thermo Fisher is also launching a compact, versatile gas chromatography
system. The Thermo
Scientific Trace™ 1300 instrument features patent-pending
innovations, including plug-n-play injectors and detectors designed to
dramatically improve laboratory productivity and lower cost in QA/QC and
routine laboratories working on environmental, chemical and food safety
applications.
The new Thermo
Scientific iCAP™ Q system brings innovation to inductively coupled
plasma mass spectrometry (ICP-MS). It features unique ion-focusing
technology that delivers improved signal-to-noise performance and
increases laboratory throughput by up to 50 percent when compared to
current systems. The iCAP Q is ideal for environmental, metals, clinical
research, food safety, semiconductor and geochemical laboratories
conducting both routine and complex elemental analyses.
Making its Pittcon debut is the Thermo
Scientific Q Exactive™ high-performance benchtop Orbitrap™ LC-MS/MS,
the first commercially available instrument to bring together
high-performance quadrupole MS capability with the ultrahigh-resolution
accurate mass Orbitrap platform. Customers can be more confident in the
qualitative and quantitative results from the Q Exactive mass
spectrometer than from existing quadrupole time-of-flight (Q-Tof)
instruments on the market. In laboratories where researchers are
performing protein identification, metabolism, forensic toxicology or
food safety analyses, “Quanfirmation™” makes it possible to identify,
quantify and confirm in one experiment – significantly improving
productivity and creating a more efficient workflow.
The company continues its leadership in the miniaturization of
technology by introducing the Thermo
Scientific NanoDrop® Lite instrument, a compact, personal
microvolume UV-Vis spectrophotometer that complements full-featured
NanoDrop instruments and places advanced analysis in the hands of every
researcher.
And finally, Thermo Fisher recently launched the Thermo
Scientific TruNarc™ narcotics analyzer, a handheld instrument that
allows law enforcement personnel to rapidly and reliably identify
illicit drugs at the scene of a crime.
Enterprise-Level Services and Support Drive Customer Productivity
Thermo Fisher recently launched Unity Lab Services to address
productivity at the highest level in a laboratory environment. This
unique combination of service and support provides a range of
capabilities, from traditional laboratory instrument and equipment
maintenance services to enterprise-level support, including management
of laboratory staffing and consumables inventory. These services can be
implemented across a broad range of laboratory environments and can be
scaled from service on a single instrument to a highly customized,
comprehensive service program at the laboratory, site or enterprise
level.
Laboratory managers will also benefit from the Thermo Scientific CONNECTS
for the Paperless Lab™ software solution. The CONNECTS system
leverages existing investments in software systems, databases and
laboratory instrumentation from a variety of vendors to transform that
data into information that can be used across the enterprise. CONNECTS
reduces the time and cost associated with manual data handling and
improves data integrity.
For access to all Thermo Fisher news and product photos related to
Pittcon 2012, please visit our online media room at www.thermofisher.com/news.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving
science. Our mission is to enable our customers to make the world
healthier, cleaner and safer. With revenues of $12 billion, we have
approximately 39,000 employees and serve customers within pharmaceutical
and biotech companies, hospitals and clinical diagnostic labs,
universities, research institutions and government agencies, as well as
in environmental and process control industries. We create value for our
key stakeholders through three premier brands, Thermo Scientific, Fisher
Scientific and Unity™ Lab Services, which offer a unique combination of
innovative technologies, convenient purchasing options and a single
solution for laboratory operations management. Our products and services
help our customers solve complex analytical challenges, improve patient
diagnostics and increase laboratory productivity. Visit www.thermofisher.com.
The following constitutes a “Safe Harbor” statement under the Private
Securities Litigation Reform Act of 1995: This press release contains
forward-looking statements that involve a number of risks and
uncertainties. Important factors that could cause actual results to
differ materially from those indicated by such forward-looking
statements are set forth in the company’s Annual Report on Form 10-K for
the year ended December 31, 2011, under the caption “Risk Factors,”
which is on file with the Securities and Exchange Commission and
available in the “Investors” section of our website under the heading
“SEC Filings.” Important factors that could cause actual results to
differ materially from those indicated by forward-looking statements
include risks and uncertainties relating to: the need to develop new
products and adapt to significant technological change; implementation
of strategies for improving growth; general worldwide economic
conditions and related uncertainties; dependence on customers' capital
spending policies and government funding policies; the effect of
exchange rate fluctuations on international operations; the effect of
healthcare reform legislation; use and protection of intellectual
property; the effect of changes in governmental regulations; and the
effect of laws and regulations governing government contracts, as well
as the possibility that expected benefits related to the acquisitions of
Dionex and Phadia may not materialize as expected. While we may elect to
update forward-looking statements at some point in the future, we
specifically disclaim any obligation to do so, even if estimates change
and, therefore, you should not rely on these forward-looking statements
as representing our views as of any date subsequent to today.
Source: Thermo Fisher Scientific
For Thermo Fisher Scientific Inc.
Media:
Ron O’Brien,
781-622-1242
ron.obrien@thermofisher.com
or
Investors:
Ken
Apicerno, 781-622-1294
ken.apicerno@thermofisher.com
Website:
www.thermofisher.com
